Assignee profile:

UNIVERSITE DE GENEVE

City:

GENEVA 4

Country:

Switzerland

Published Applications:

15

Last publication date:

2016-03-10

Patent Grants:

8

Last grant date:

2017-05-23

Top Inventors for applications by UNIVERSITE DE GENEVE

These are the the leading inventors for applications assigned to UNIVERSITE DE GENEVE:

Recent patent applications by UNIVERSITE DE GENEVE

UNIVERSITE DE GENEVE based in GENEVA 4, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-03-10
US20160067212A1
Human necessities

USE OF INSULIN SIGNALING ANTAGONISTS, OPTIONALLY IN COMBINATION OF TRANSFECTION OF NON-BETA CELLS, FOR INDUCING INSULIN PRODUCTION

#2 | 2015-08-27 ✅ Patent 9,657,064 granted on 2017-05-23
US20150239938A1
Chemistry; metallurgy

Cell penetrating peptides

#3 | 2014-05-29 ✅ Patent 9,518,098 granted on 2016-12-13
US20140147440A1
Chemistry; metallurgy

Uses of NANOG inhibitors and related methods

#4 | 2014-03-20 ✅ Patent 9,351,988 granted on 2016-05-31
US20140080779A1
Human necessities

Macrocyclic lactones and use thereof

#5 | 2014-02-13 ✅ Patent 9,757,037 granted on 2017-09-12
US20140046195A1
Human necessities

In vivo bioluminescence monitoring apparatus

#6 | 2013-09-26
US20130252834A1
Physics

Diagnostic Methods

#7 | 2013-05-30 ✅ Patent 8,828,390 granted on 2014-09-09
US20130136737A1
Human necessities

Uses of NOGO-A inhibitors and related methods

#8 | 2013-05-23 ✅ Patent 9,549,985 granted on 2017-01-24
US20130131190A1
Human necessities

Compositions comprising polymers prepared from 2-hydroxyalkyl acids

#9 | 2013-01-31
US20130028920A1
Human necessities

STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF

#10 | 2013-01-17
US20130017197A1
Human necessities

STABILIZED ANTIBODY PREPARATIONS AND USES THEREOF

#11 | 2012-09-13 ✅ Patent 9,187,534 granted on 2015-11-17
US20120231030A1
Chemistry; metallurgy

Multi-epitopic vaccine

#12 | 2012-08-30
US20120219538A1
Human necessities

STABILIZED PROTEIN FORMULATIONS AND USE THEREOF

#13 | 2011-06-09
US20110136160A1
Physics

ANALYSIS OF GLYCATED PROTEINS

#14 | 2010-12-16 ✅ Patent 9,155,745 granted on 2015-10-13
US20100316638A1
Human necessities

Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs

#15 | 2009-03-26
US20090081122A1
Human necessities

Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant

Also check out UNIVERSITE DE GENEVE's (GENEVA 4, Switzerland) applicant profile with 5 patent applications submitted.

AssigneeID:

4697 ⎘